Innovation Pharmaceuticals Inc (IPIX)

[BonelessCat]

There are Renal Cell Carcinomas that are highly drug resistant including Sunitinib. Pfizer hopes that Kevetrin will increase Sunitinib efficacy against all renal carcinomas and eliminate even the most drug resistant.

Second, the studies include at least two treatment groups in a comparative protocol where outcomes for all groups, Kevitrin and Kevetrin/Sunitinib, are directly contrasted. The proof of theory goal is that Kevetrin allows for greater tumor growth arrest and shrinkage than Sunitinib alone.